Zobrazeno 1 - 10
of 616 793
pro vyhledávání: '"IMMUNODEFICIENCY"'
Autor:
Dankwa S; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America., Kosman C; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America., Dennis M; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America., Giorgi EE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Vuong K; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America., Pahountis I; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America., Garza A; Department of Surgery, Duke University School of Medicine, Durham, NC, United States of America.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States of America., Binuya C; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America., McCarthy J; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, United States of America.; Center for Human Systems Immunology, Duke University, Durham, NC, United States of America., Mayer BT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Ngo JT; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, United States of America., Enemuo CA; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, United States of America., Carnathan DG; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, United States of America., Stanfield-Oakley S; Department of Surgery, Duke University School of Medicine, Durham, NC, United States of America.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States of America., Berendam SJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States of America., Weinbaum C; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America., Engelman K; Department of Medicine, UMass Chan Medical School, Worcester, MA, United States of America., Magnani DM; Department of Medicine, UMass Chan Medical School, Worcester, MA, United States of America., Chan C; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, United States of America.; Center for Human Systems Immunology, Duke University, Durham, NC, United States of America., Ferrari G; Department of Surgery, Duke University School of Medicine, Durham, NC, United States of America.; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, United States of America., Silvestri G; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, United States of America.; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States of America., Amara RR; Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA, United States of America.; Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, United States of America., Chahroudi A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States of America.; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta and Emory University, Atlanta, GA, United States of America., Permar SR; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America.; Gale and Ira Drukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, United States of America., Fouda GG; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America.; Gale and Ira Drukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, United States of America., Goswami R; Department of Pediatrics, Weill Cornell Medicine, New York, NY, United States of America.; Gale and Ira Drukier Institute for Children's Health, Weill Cornell Medicine, New York, NY, United States of America.
Publikováno v:
PloS one [PLoS One] 2024 Nov 11; Vol. 19 (11), pp. e0312411. Date of Electronic Publication: 2024 Nov 11 (Print Publication: 2024).
Autor:
Sadeghi L; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran., Bolhassani A; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. Electronic address: azam.bolhassani@yahoo.com., Mohit E; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Protein Technology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: el_mohit@yahoo.com., Baesi K; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran., Aghasadeghi MR; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran., Milani A; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran., Agi E; Iranian Comprehensive Hemophilia Care Center, Tehran, Iran.
Publikováno v:
Microbial pathogenesis [Microb Pathog] 2024 Aug; Vol. 193, pp. 106749. Date of Electronic Publication: 2024 Jun 13.
Autor:
Zhao J; Department of Infectious Disease and Clinical Microbiology, Beijing Chaoyang Hospital, Capital Medical University., Zhou X; Department of biosafety, China Biotechnology Co. Ltd, Beijing, China., Qiu Y; Laboratory Animal Center of the Academy of Military Medical Sciences., Jia R; Department of biosafety, China Biotechnology Co. Ltd, Beijing, China.
Publikováno v:
AIDS (London, England) [AIDS] 2024 Sep 01; Vol. 38 (11), pp. 1617-1626. Date of Electronic Publication: 2024 May 30.
Autor:
Ding AK; Department of Biology, Boston College, Chestnut Hill, Massachusetts, USA., Wallis ZK; Department of Biology, Boston College, Chestnut Hill, Massachusetts, USA., White KS; Department of Biology, Boston College, Chestnut Hill, Massachusetts, USA., Sumer CE; Department of Biology, Boston College, Chestnut Hill, Massachusetts, USA., Kim WK; Division of Microbiology, Tulane National Primate Research Center, Tulane University, Covington, Louisiana, USA.; Department of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA., Ardeshir A; Division of Microbiology, Tulane National Primate Research Center, Tulane University, Covington, Louisiana, USA.; Department of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA., Williams KC; Department of Biology, Boston College, Chestnut Hill, Massachusetts, USA.
Publikováno v:
AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2024 Sep; Vol. 40 (9), pp. 531-542. Date of Electronic Publication: 2024 Jun 12.
Autor:
Donato G; Università di Messina, Messina, Italy.; ASC 'I Periodeuti', Reggio Calabria, Italy., Caspanello T; Università di Messina, Messina, Italy.; ASC 'I Periodeuti', Reggio Calabria, Italy., Caprì A; ASC 'I Periodeuti', Reggio Calabria, Italy.; Clinica Veterinaria Camagna-VetPartners, Reggio Calabria, Italy., De Majo M; Università di Messina, Messina, Italy.; ASC 'I Periodeuti', Reggio Calabria, Italy., Iannelli NM; Università di Messina, Messina, Italy.; ASC 'I Periodeuti', Reggio Calabria, Italy.; Clinica Veterinaria Camagna-VetPartners, Reggio Calabria, Italy., Rosace F; Università di Messina, Messina, Italy.; ASC 'I Periodeuti', Reggio Calabria, Italy.; Clinica Veterinaria Camagna-VetPartners, Reggio Calabria, Italy., Bruno F; National Reference Center for Leishmaniasis (C.Re.Na.L.), Istituto Zooprofilattico Sperimentale della Sicilia, Palermo, Italy., Castelli G; National Reference Center for Leishmaniasis (C.Re.Na.L.), Istituto Zooprofilattico Sperimentale della Sicilia, Palermo, Italy., Pennisi MG; ASC 'I Periodeuti', Reggio Calabria, Italy. mariagrazia.pennisi@unime.it., Masucci M; Università di Messina, Messina, Italy.; ASC 'I Periodeuti', Reggio Calabria, Italy.
Publikováno v:
Parasites & vectors [Parasit Vectors] 2024 Jul 30; Vol. 17 (1), pp. 324. Date of Electronic Publication: 2024 Jul 30.
Autor:
Boopathy AV; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA., Nekkalapudi A; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA., Sung J; Drug Metabolism, Gilead Sciences, Inc., Foster, California, USA., Schulha S; Virology, Hookipa Pharma Inc., New York, New York, USA., Jin D; Protein Therapeutics, Gilead Sciences, Inc., Foster, California, USA., Sharma B; Discovery Virology, Gilead Sciences, Inc., Foster, California, USA., Ng S; Oncology, Gilead Sciences, Inc., Foster, California, USA., Lu S; Protein Therapeutics, Gilead Sciences, Inc., Foster, California, USA., Wimmer R; Virology, Hookipa Pharma Inc., New York, New York, USA., Suthram S; Bioinformatics, Gilead Sciences, Inc., Foster, California, USA., Ahmadi-Erber S; Virology, Hookipa Pharma Inc., New York, New York, USA., Lauterbach H; Global Research and Development, Hookipa Pharma Inc., New York, New York, USA., Orlinger KK; Global Research and Development, Hookipa Pharma Inc., New York, New York, USA., Hung M; Protein Therapeutics, Gilead Sciences, Inc., Foster, California, USA., Carr B; Drug Metabolism, Gilead Sciences, Inc., Foster, California, USA., Callebaut C; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA., Geleziunas R; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA., Kuhne M; Oncology, Gilead Sciences, Inc., Foster, California, USA., Schmidt S; Virology, Hookipa Pharma Inc., New York, New York, USA., Falkard B; Clinical Virology, Gilead Sciences, Inc., Foster, California, USA.
Publikováno v:
Journal of virology [J Virol] 2024 Jul 23; Vol. 98 (7), pp. e0029424. Date of Electronic Publication: 2024 Jun 03.
Autor:
Rodríguez-Frade JM; Department of Immunology and Oncology, Chemokine Signaling Group, Centro Nacional de Biotecnología/CSIC, Madrid, Spain., González-Granado LI; Department of Pediatrics, 12 de Octubre Health Research Institute (imas12), Madrid, Spain.; Department of Public Health School of Medicine, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain., Santiago CA; X-ray Crystallography Unit, Centro Nacional de Biotecnología/Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain., Mellado M; Department of Immunology and Oncology, Chemokine Signaling Group, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Jul 05; Vol. 15, pp. 1406532. Date of Electronic Publication: 2024 Jul 05 (Print Publication: 2024).
Autor:
Singh B, Sharan R, Ravichandran G, Escobedo R, Shivanna V, Dick EJ Jr, Hall-Ursone S, Arora G, Alvarez X, Singh DK, Kaushal D, Mehra S
Publikováno v:
JCI insight [JCI Insight] 2024 Jul 02; Vol. 9 (15). Date of Electronic Publication: 2024 Jul 02.
Autor:
Altman PX; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America., Ozorowski G; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Stanfield RL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Haakenson J; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.; Applied Biomedical Science Institute, San Diego, California, United States of America., Appel M; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Parren M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Lee WH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Sang H; Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medical, Kansas State University, Manhattan, Kansas, United States of America., Woehl J; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Saye-Francisco K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Joyce C; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America., Song G; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America., Porter K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Landais E; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Andrabi R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Wilson IA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, United States of America., Ward AB; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Mwangi W; Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medical, Kansas State University, Manhattan, Kansas, United States of America., Smider VV; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.; Applied Biomedical Science Institute, San Diego, California, United States of America., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America., Sok D; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America.; Global Health Investment Corporation, New York, New York, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2024 Sep 09; Vol. 20 (9), pp. e1012042. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).
Autor:
Gai Y; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China., Gao N; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China., Mou Z; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China., Yang C; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China., Wang L; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China., Ji W; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China., Gu T; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China., Yu B; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China., Wang C; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China., Yu X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.; Key Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China., Gao F; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.; Institute of Molecular and Medical Virology, School of Medicine, Jinan University, Guangzhou 510632, China.; Key Laboratory of Viral Pathogenesis & Infection Prevention and Control, Jinan University, Ministry of Education, Guangzhou 510632, China.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Jun 29; Vol. 25 (13). Date of Electronic Publication: 2024 Jun 29.